{"name":"NovaDigm Therapeutics, Inc.","slug":"novadigm-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NDV-3 vaccine without alum ID","genericName":"NDV-3 vaccine without alum ID","slug":"ndv-3-vaccine-without-alum-id","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NDV-3 vaccine without alum ID","genericName":"NDV-3 vaccine without alum ID","slug":"ndv-3-vaccine-without-alum-id","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQVWQxTDdWUnBzTFRkS0t4WDhMd08yQnpMekljN3ZqTnl3QjJwRU9nd05JY0lpRzZNMlNSa3Z3OGVLeFd2OVZIOFFaSm1sWUdWYXdaVTl4QVpDMG1lTFp5ajVuclFuU3JzNjdwUlNaeFFxSm9GSTVmcTdYaWZQS251akZEeGVUNmV6QVdvWm9JSThrdm5Id1JlblRRMUxPZTdDWVVuSXJId1p1a3ZhNlpwU0xCbEtIa2FhVHY4VDN0VEIwaUhab2otOUJ6RldaajNFTHZLZEtqTVNjNTRobDVkdm1DNklLbmhYbUZ0SDIyT1FtaTFyYlgwRUtXeVR0ZjhDLUptMEZpVV9DWE4ySFhtVWlDMDA4TF9LbHpvVmhjbWw3TkVl?oc=5","date":"2026-02-09","type":"pipeline","source":"PR Newswire UK","summary":"Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZURWaUdTdEY1Q04wSndiaVhoaXlEVUFvd2N2RmZ6RThzVlcyOEhKOVhIZkFCQmJsMXFCUFBxX09xM2FCbFNqWlVXcHVLUFdlaUp4UjBUajdOby0zeFFubUZHLUwtY2ZxMTlpeXRBSi1td2ZDZUJaY0s3YkdvRU5lQkMzd1FvZ0VvWXNoVXJvbkhqZUl3LVA4V3dwZHhUcHNzeEJVX1FOblFnaHM?oc=5","date":"2018-04-25","type":"trial","source":"Clinical Trials Arena","summary":"NovaDigm publishes vulvovaginal candidiasis vaccine study results - Clinical Trials Arena","headline":"NovaDigm publishes vulvovaginal candidiasis vaccine study results","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}